Unlock instant, AI-driven research and patent intelligence for your innovation.

HA-Fc fusion protein and preparation method and vaccine thereof

A fusion protein, ha-fc technology, applied in the field of biomedicine, can solve the problems of low immunogenicity, low yield, high pathogenicity, etc., and achieve the effect of high immunogenicity

Active Publication Date: 2020-03-10
天康制药股份有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, traditional avian influenza vaccines are inactivated vaccines or live attenuated vaccines. These methods have the advantages of high efficiency and rapidity, but there are still many problems in the production of avian influenza vaccines. For example, wild-type avian influenza viruses are highly pathogenic, and the use of chicken Avian influenza vaccines made from embryos have lower yields than human influenza vaccines, as well as problems such as low immunogenicity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HA-Fc fusion protein and preparation method and vaccine thereof
  • HA-Fc fusion protein and preparation method and vaccine thereof
  • HA-Fc fusion protein and preparation method and vaccine thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] Avian influenza HA-Fc gene synthesis:

[0078] The avian influenza HA gene was obtained according to the login to GenBank, and the gene sequence was obtained from GenBank: ABW90137.1. After optimization of codon preference, the HA gene sequence is shown in SEQ ID NO.1. The sequence of the Fc region of porcine IgM is shown in SEQ ID NO.2, and the sequence of the Fc region of human IgG is shown in SEQ ID NO.3. The HA gene was spliced ​​with the Fc region of porcine IgM and the Fc region of human IgG respectively; a His tag with 6 histidines was added to the N-terminus, restriction sites HindIII and BamHI were inserted at both ends of the gene, and sent to the synthetic company Perform gene synthesis.

Embodiment 2

[0080] pcDNA TM 3.1-HA-Fc plasmid construction

[0081] 1. Ligation reaction: Ligation of the recovered PCR product and pcDNA3.1, the ligation system (10 μL / tube) is as follows: 1 μL of pcDNA3.1 vector, 2 μL of the recovered enzyme digestion product, ddH 2 O 2 μL, Solution I 5 μL, and connect overnight on the connection instrument at 16°C.

[0082] 2. Preparation of Escherichia coli competent cells: Pick a single colony from a petri dish and inoculate it into a test tube containing 10 mL of LB liquid medium, and culture overnight at 37°C. Take 100 μL of the bacterial solution and transfer it to a centrifuge tube containing 10 mL of liquid LB medium, incubate with shaking at 37°C for 2 hours; divide the bacterial solution into 1.5mL centrifuge tubes, and place in an ice bath for 20 minutes; centrifuge at 4,000 rpm for 5 minutes at 4°C, discard the supernatant ;Add 1 / 5 volume (200μL) of pre-cooled CaCl 2 Buffer, gently suspend the cells; centrifuge at 4000rpm at 4°C for 5min,...

Embodiment 3

[0088] Preparation of HA-Fc fusion protein by CHO expression system

[0089] 1. Cell Culture

[0090] CHO-S cells, cultured at 37°C, 5% CO 2 , 125rpm, and the culture medium (Hycell+8mM GlutaMAX) was purchased from HyClone Company. FreeStyle TM MAX reagent was purchased from Invitrogen Company. The density and viability of CHO-S cells were counted and observed by trypan blue staining. CHO-S cell suspension culture, cell density 1.5×10 6 / mL, transfection was performed when the cell viability was ≥90%. Cultured in a shaking shaker incubator, culture parameters: 37 ° C, 5% CO 2 , 125rpm.

[0091] 2. Plasmid extraction: through PureLink TM The instructions of Hipure Plasmid Maxiprep Kit (endotoxin-free) kit require extraction of recombinant plasmids for transfection.

[0092] 3. Transfection: pcDNA TM 3.1-HA-Fc plasmid using FreeStyle TM MAX Reagent was transfected into CHO-S cells, and the cell supernatant was collected after 14 days to obtain the desired antigen. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an HA-Fc fusion protein and a preparation method and vaccine thereof, and relates to the technical field of biological medicines. The HA-Fc fusion protein contains an avian influenza HA segment and an Fc region of an antibody, a C segment of the avian influenza HA segment is connected to the Fc region of the antibody, and the HA-Fc fusion protein is expressed by a CHO cell expression system. The HA-Fc fusion protein has high immunogenicity of an avian influenza antigen.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to an HA-Fc fusion protein, a preparation method thereof and a vaccine. Background technique [0002] Highly pathogenic avian influenza (HPAI) is a severe zoonotic infectious disease caused by influenza A virus. As the main source of animal infection, chickens pose a continuous threat to human public health. In 1997, Hong Kong first reported poultry and human infection of highly pathogenic avian influenza H5N1, and then the disaster swept the world, causing more than 500 people to be infected, with a mortality rate as high as 60%. Influenza A virus belongs to the Orthomyxoviridae family, and is divided into different subtypes according to the two glycoproteins of hemagglutinin (HA) and neuraminidase (NA) on the surface of the virus. So far, 16 HA subtypes (H1-H16) and 9 NA subtypes (N1-N9) have been identified. [0003] At present, traditional avian influenza vaccines are inac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/70C12N15/85A61K39/145A61P31/16
CPCC07K14/005C12N15/85C12N15/70A61K39/12A61P31/16C12N2760/16122C07K2319/21C07K2319/30C12N2760/16134
Inventor 贺笋于新茂杨颖潘毅平李俊辉张国庆张伟程兰玲高窦张莹周冰心饶婷婷
Owner 天康制药股份有限公司